Free US stock support and resistance levels with price projection models for strategic trading decisions. Our technical levels are calculated using sophisticated algorithms that identify the most significant price barriers.
Supernus Pharmaceuticals Inc. (SUPN) is a specialty pharmaceutical firm focused on central nervous system therapies, trading at a current price of $50.54 as of 2026-04-06, marking a modest 0.12% gain on the day. This analysis covers key technical levels, recent market context, and potential scenarios for the stock as it trades in a well-defined near-term range. Currently, no recent earnings data is available for SUPN, so market participants are leaning heavily on technical signals and sector tre
Is Supernus Pharmaceuticals (SUPN) Stock Gaining Momentum | Price at $50.54, Up 0.12% - Top Breakouts
SUPN - Stock Analysis
4908 Comments
1358 Likes
1
Joeanne
Senior Contributor
2 hours ago
This feels like I should bookmark it and never return.
👍 165
Reply
2
Light
Elite Member
5 hours ago
Talent like this deserves recognition.
👍 271
Reply
3
Danean
Expert Member
1 day ago
Could’ve done things differently with this info.
👍 105
Reply
4
Ameenah
Trusted Reader
1 day ago
As a beginner, I didn’t even know to look for this.
👍 278
Reply
5
Zaidee
Community Member
2 days ago
I understood nothing but I’m thinking hard.
👍 183
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.